On September 29, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and have a company presentation at the following investor conferences (Press release, Herantis Pharma, SEP 29, 2021, View Source,c3423626 [SID1234590460]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sachs 21st Annual Biotech in Europe Forum, October 7th – 8th, 2021, Digital Conference

1×1 meetings and virtual presentation

Redeye Neurology Seminar CNS – October 13th, 2021

Virtual Presentations at 10:00 – 13:00 EEST / 9:00 – 12:00 CEST

Antti Vuolanto, Chief Operating Officer will have a company presentation at:

Turun Talouspäivät: Säästä ja Sijoita – October 22nd – 23rd, 2021

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the organizers at the Sachs, Redeye, and Turun Talouspäivät if you wish to attend and/or schedule a meeting with Herantis.